MLi-2 is an orally active, highly selective LRRK2 inhibitor with potential for use in Parkinson's disease research.
- Size: 1mg
- Purity: ≥98%
- Molecular Formula: C 2 1 H 2 5 N 5 O 2
- Molecular Weight: 379.46
- Physical State: White to off-white Solid
- Storage: Powder:-20℃, 2 years;Insolvent(Mother Liquid):-20℃, 6 months;-80℃, 1 year
- Brand: Saint Michael
- Catalogue No.: IM6360-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review